Rani Therapeutics Holdings Inc

RANINASDAQ · USD
0.78USD0.00 (-1.46%)
2310

Rani Therapeutics Holdings Inc (RANI) Wheel Strategy

No qualifying wheel strategy setups were found for RANI in the prior session.

Read more

Running a RANI wheel strategy lets you generate consistent premium income on Rani Therapeutics Holdings Inc while setting your own entry and exit prices on the underlying. Rani Therapeutics Holdings Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own RANI, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best RANI wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on RANI, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable RANI wheel from a losing one.

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-alpha antibody to treat psoriatic arthritis; RT-102, a parathyroid hormone that is in preclinical studies for the treatment of osteoporosis; RT-109, a human growth hormone to treat growth hormone deficiency; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-106, a basal insulin for the treatment of type 2 diabetes.

The company was incorporated in 2012 and is headquartered in San Jose, California.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the RANI wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your RANI wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.

No illustrative rows to display.

As of September 22, 2026

Run the Wheel on RANI With Confidence

Find the best RANI wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.

Start your 14-day free trial